Hypoxia-inducible VEGF gene delivery to ischemic myocardium using water-soluble lipopolymer

Gene Therapy

Volumn 10, Issue 18, 2003, Pages 1535-1542

  Lee, M ^a   Rentz, J ^c   Bikram, M ^b   Han, S ^b   Bull, D A ^c   Kim, S W ^b  

^a Inha University School of Medicine   (South Korea)

^b UNIVERSITY OF UTAH   (United States)

^c UNIVERSITY OF UTAH HEALTH SCIENCES CENTER   (United States)

Author keywords

Hypoxia; Ischemic myocardium; Nonviral gene therapy; Vascular endothelial growth factor; Water soluble lipopolymer

Indexed keywords

LIPOSOME; POLYMER; RECOMBINANT ERYTHROPOIETIN; VASCULOTROPIN; VIRUS VECTOR; WATER;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATHEROSCLEROTIC PLAQUE; CELL PROLIFERATION; CONTROLLED STUDY; CYTOTOXICITY; DIABETIC RETINOPATHY; DRUG EFFICACY; DRUG SAFETY; ENDOTHELIUM CELL; GENE INSERTION; GENE THERAPY; GENETIC CODE; GENETIC TRANSFECTION; HEART MUSCLE ISCHEMIA; HUMAN; HUMAN CELL; HYPOXIA; IN VITRO STUDY; INCUBATION TIME; ISCHEMIC HEART DISEASE; MALE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; SIMIAN VIRUS 40; SOLUBILITY; TUMOR GROWTH; VIRAL GENE DELIVERY SYSTEM;

ANIMALS; ANOXIA; CELL DIVISION; ENDOTHELIAL GROWTH FACTORS; ENDOTHELIUM, VASCULAR; ENHANCER ELEMENTS (GENETICS); ENZYME-LINKED IMMUNOSORBENT ASSAY; ERYTHROPOIETIN; GENE EXPRESSION; GENE THERAPY; GENETIC ENGINEERING; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LIPOSOMES; LUCIFERASES; LYMPHOKINES; MODELS, ANIMAL; MYOCARDIAL ISCHEMIA; NEOVASCULARIZATION, PHYSIOLOGIC; POLYMERS; RABBITS; STEM CELLS; TRANSFECTION; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

ANIMALIA; INSERTION SEQUENCES; PEPO; SIMIAE; SIMIAN VIRUS 40;

EID: 0041876318     PISSN: 09697128     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gt.3302034     Document Type: Article

References (22)

1. Stone D et al. Viral vectors for gene delivery and gene therapy within the endocrine system. J Endocrinol 2000; 164: 103-118.
2. Han S, Mahato RI, Sung YK, Kim SW. Development of biomaterials for gene therapy. Mol Ther 2000; 2: 302-317.
3. Han S, Mahato RI, Kim SW. Water-soluble lipopolymer for gene delivery. Bioconjug Chem 2001; 12: 337-345.
4. Lee M, Han S, Ko KS, Kim SW. Cell type specific and glucose responsive expression of interleukin-4 by using insulin promoter and water soluble lipopolymer. J Control Release 2001; 75: 421-429.
5. Lee M et al. Water soluble lipopolymer as an efficient carrier for gene delivery to myocardium. Gene Therapy 2003; 10: 585-593.
6. Isner JM. Myocardial gene therapy. Nature 2002; 415: 234-239.
7. Brogi E et al. Hypoxia-induced paracrine regulation of vascular endothelial growth factor receptor expression. J Clin Invest 1996; 97: 469-476.
8. Lee JS, Feldman AM. Gene therapy for therapeutic myocardial angiogenesis: a promising synthesis of two emerging technologies. Nat Med 1998; 4: 739-742.
9. Springer ML et al. VEGF gene delivery to muscle: potential role for vasculogenesis in adults. Mol Cell 1998; 2: 549-558.
10. Lee RJ et al. VEGF gene delivery to myocardium; deleterious effects of unregulated expression. Circulation 2000; 102: 898-901.
11. Maxwell PH, Pugh CW, Ratcliffe PJ. Inducible operation of the erythropoietin 3′ enhancer in multiple cell lines; evidence for a widespread oxygen-sensing mechanism. Proc Natl Acad Sci USA 1993; 90: 2423-2427.
12. Jiang B-H et al. Dimerization, DNA binding, and transactivation properties of hypoxia-inducible factor 1. J Biol Chem 1996; 271: 17771-17778.
13. Wang GL, Semenza GL. General involvement of hypoxia-inducible factor 1 in transcriptional response to hypoxia. Proc Natl Acad Sci USA 1993; 90: 4304-4308.
14. Chavand O, Spilsbury K, Rakoczy PE. Addition of a c-myc epitope tag within the VEGF protein does not affect in vitro biological activity. Biochem Cell Biol 2001; 79: 107-112.
15. Levy AP, Levy NS, Wegner S, Goldberg MA. Transcriptional regulation of the rat vascular endothelial growth factor gene by hypoxia. J Biol Chem 1995; 270: 13333-13340.
16. Liu Y, Cox SR, Morita T, Kourembanas S. Hypoxia regulates vascular endothelial growth factor gene expression in endothelial cells. Identification of a 5′ enhancer. Circ Res 1995; 77: 638-643.
17. Forsythe JA et al. Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Mol Cell Biol 1996; 16: 4604-4613.
18. Stein I et al. (1995) Stabilization of vascular endothelial growth factor mRNA by hypoxia and hypoglycemia and coregulation with other ischemia-induced genes. Mol Cell Biol 1995; 15: 5363-5368.
19. Dibbens JA et al. Hypoxic regulation of vascular endothelial growth factor mRNA stability requires the cooperation of multiple RNA elements. Mol Biol Cell 1999; 10: 907-919.
20. Su H, Arakawa-Hoyt J, Kan YW. Adeno-associated viral vector-mediated hypoxia response element-regulated gene expression in mouse ischemic heart model. Proc Natl Acad Sci USA 2002; 99: 9480-9485.
21. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987; 162: 156-159.
22. Operschall C, Falivene L, Clozel JP, Roux S. A new model of chronic cardiac ischemia in rabbits. J Appl Physiol 2000; 88: 1438-1445.